A Review on T POXX (TECOVIRIMAT)—A New Bioweapon Against Small Pox

Authors

  • M. Manasa Rekha Department of Pharmacy Practice, Annamacharya college of Pharmacy, Rajampet, Andhra Pradesh, India.

DOI:

https://doi.org/10.37591/rrjom.v8i2.418

Abstract

As an author in the present review, I have provided all the available information regarding T POXX (TECOVIRIMAT)—a new bioweapon against small pox—like its synonym, history of discovery and approval, chemical structure, pharmacology, adverse drug reactions, drug interactions, safety concerns, contraindications, warnings/cautions, preclinical and clinical trial information and all other information after thoroughly searching in all the available resources. I hope this can be helpful to all the healthcare professionals and students to understand, grasp easily and recall quickly.

 

Keywords: POXX (TECOVIRIMAT), bioweapon, pharmacology, adverse drug reactions, drug interactions

Cite this Article

Rekha MM. A Review on T POXX (TECOVIRIMAT)—A New Bioweapon Against Small Pox. Research & Reviews: Journal of Medicine. 2018; 8(2): 9–11p.

Downloads

Published

2018-09-25

Issue

Vol. 8 No. 2 (2018)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.